The invention relates to new substituted heteroaryls of formula11, or of formula1'1', whereinAis either N or CH, whereinR2is selected from the group consisting of -C1-3-alkyl, -C1-3-haloalkyl, F, Br, Cl, whereinYis selected from -O- or -CH2-, and whereinR3is defined as in claim 1, and the pharmaceutically acceptable salts thereof, and the use of these aforementioned compounds for the treatment of diseases such as asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.本發明係關於新穎之經取代之式1雜芳基化合物1, 或式1'雜芳基化合物1', 其中A為N或CH, 其中R2係選自由以下組成之群:-C1-3烷基、-C1-3鹵烷基、F、Br、Cl, 其中Y係選自-O-或-CH2-, 且其中R3如技術方案1所定義,及其醫藥學上可接受之鹽, 及此等前述化合物用於治療諸如哮喘、COPD、過敏性鼻炎、過敏性皮炎、紅斑狼瘡、狼瘡性腎炎及類風濕性關節炎之疾病的用途。